<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38387538</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1555-7162</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Feb</Month><Day>20</Day></PubDate></JournalIssue><Title>The American journal of medicine</Title><ISOAbbreviation>Am J Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Determinants of Long-Term Post-COVID Conditions in the United States: 2022 Behavioral Risk Factor Surveillance System.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0002-9343(24)00090-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjmed.2024.02.010</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significant proportion of COVID survivors experience lingering and debilitating symptoms following acute COVID-19 infection. According to the national research plan on long COVID, it is a national priority to identify the prevalence of post-COVID conditions and their associated factors.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We performed a cross-sectional analysis of the Prevention Behavioral Risk Factor Surveillance System (BRFSS) 2022, the largest continuously gathered health survey dataset worldwide by the Centers for Disease Control. After identifying individuals with a positive history of COVID-19, we grouped COVID-19 survivors based on whether they experienced long-term post-COVID conditions. Using survey-specific R packages, we compared the two groups' socio-demographics, comorbidities, and lifestyle-related factors. A logistic regression model was used to identify factors associated with post-COVID conditions.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall estimated prevalence of long-term post-COVID conditions among COVID survivors was 21.7%. Fatigue (5.7%), dyspnea (4.2%), and anosmia/ageusia (3.8%) were the most frequent symptoms. Based on multivariate logistic regression analysis, female sex, body mass index (BMI)&#x2265;25, lack of insurance, history of pulmonary disease, depression, and arthritis, being a former smoker, and sleep duration &lt;7 h/d were associated with higher odds of post-COVID conditions. On the other hand, age &gt;64 y/o, Black race, and annual household income &#x2265;$100k were associated with lower odds of post-COVID conditions.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings indicate a notable prevalence of post-COVID conditions, particularly among middle-aged women and individuals with comorbidities or adverse lifestyles. This high-risk demographic may require long-term follow-up and support. Further investigations are essential to facilitate the development of specified healthcare and therapeutic strategies for those suffering from post-COVID conditions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hejazian</LastName><ForeName>Seyyed Sina</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, The Pennsylvania State University, Hershey, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadr</LastName><ForeName>Alireza Vafaei</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahjouei</LastName><ForeName>Shima</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Penn State Health Milton S. Hershey Medical Center, Hershey, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vemuri</LastName><ForeName>Ajith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, The Pennsylvania State University, Hershey, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Vida</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, College of Medicine, Pennsylvania State University, Hershey, Pa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zand</LastName><ForeName>Ramin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, College of Medicine, The Pennsylvania State University, Hershey, Pa. Electronic address: ramin.zand@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med</MedlineTA><NlmUniqueID>0267200</NlmUniqueID><ISSNLinking>0002-9343</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID conditions</Keyword><Keyword MajorTopicYN="N">Post-acute Sequelae of SARS-CoV-2 infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>22</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38387538</ArticleId><ArticleId IdType="doi">10.1016/j.amjmed.2024.02.010</ArticleId><ArticleId IdType="pii">S0002-9343(24)00090-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>